SAPA BD&L Webinar Session 2: Search, Evaluation & Due Diligence

Posted 2021-04-10 美中药协SAPA

Search, Evaluation

& Due Diligence

Thu, May 25, 2017

8:30 pm - 10:00 pm EDT

Part 1: Search and Evaluation - 

The Critical Initial Step of a Successful Partnership

BD is an important function that supports corporate strategy   and can bring significant value to the company. S&E is the initial step   of a successful partnership. This presentation will give a high level   introduction about S&E function in the BD organization. From both buyer   and seller perspectives, describe how BD identifies opportunities that meet company   strategic needs, how target programs are initially evaluated, and how   important steps are properly handled in the process. 

Part 2: Due Diligence - 

The devil is in the detail

After an opportunity is identified by Search & Evaluation (S&E) and endorsed by management, Due Diligence (DD) is the crucial next step prior to a specific transaction decision. From the buyer perspective, the purpose of DD is to acquire and validate objective and reliable information from the seller, and to make a recommendation based on the evaluation of benefits and risks. This session will provide an overview of the DD process, key learnings, and lessons learned.

Organizer

Co-Organizer

Tittle Sponsor

Registration Link

https://attendee.gotowebinar.com/register/7089154379005868547

Or please click "Read More" at the bottom of the page.

Distinguished Panelists:

Bing Yuan

SVP, Global Head of Corporate Development

CStone Pharmaceuticals

Dr. Bing Yuan is currently SVP and Global Head of Corporate Development at CStone Pharmaceuticals. He is a seasoned business executive with extensive experience in business development and marketing strategy, made significant contributions to seven oncology brands. Before joining CStone, he was Executive Director and Global Lead of Oncology BD at Merck (MSD). He focused on expanding Merck's leadership position in cancer immunotherapy, and successfully achieved 34 M&A, licensing and Keytruda collaboration deals. Before Merck, he was Marketing Executive Director at Novartis Oncology, responsible for brand life cycle strategy for Glivec and Afinitor, two blockbuster cancer drugs.  He participated in global launch of Zykadia in lung cancer and was a core deal team member that in-licensed Jakavi from Incyte. He was three-time Novartis Oncology President Award recipient. He also served as Global Oncology Marketing Lead at Eisai in the past, managing entire oncology portfolio. Dr. Yuan holds a Ph.D. in Molecular Biology from Columbia University, a MBA from Cornell University and a BS in Biochemistry from Nanjing University.

Feng (Aaron) Chen

Director, Global BD&L

Bayer

Dr.   Feng (Aaron) Chen is currently Director of Global Business Development &   Licensing at Bayer Pharmaceuticals, accountable for leading business   development efforts in Oncology and other Specialty Therapeutic Areas.  Dr. Chen has 15 years of experience in   academia, consulting, biotech, and pharmaceutical industries.  Dr. Chen has been with Bayer since 2010   with increasing responsibilities in Strategic Planning, Market Access, and   Marketing.  In his marketing role, he   led efforts for Xarelto® and a set of established products and strategic   alliance with Johnson & Johnson and other partners.  Prior to Bayer, Dr. Chen worked at McKinsey   & Company as a consultant, supporting large pharma clients with   development of R&D, marketing and sales strategic recommendations.  Dr. Chen started his career as a research   analyst at Beijing Genomics Institute.    Dr. Chen obtained his B.S. degree from the University of Science and   Technology of China, and M.S. and Ph.D. degrees from the University of   Pennsylvania.  Dr.   Chen authored / co-authored 10 articles in top peer-reviewed journals,   including Science, Nature Reviews Drug Discovery.

        Next...

        2017 SAPA Webinar Series “Business        Development and Licensing”

                Session 3 – June 29, 2017

        Wechat Edit by Ruling Feng

Please click here for registration!!